Vascular actions of diadenosine phosphates

Journal of Autonomic Pharmacology

Volumn 16, Issue 6, 1996, Pages 357-362

  Schluter H ^a   Tepel, M ^a   Zidek, W ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; ANGIOTENSIN; BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; CALCIUM; CATECHOLAMINE; DIADENOSINE DIPHOSPHATE; DIADENOSINE HEXAPHOSPHATE; DIADENOSINE PENTAPHOSPHATE; DIADENOSINE PHOSPHATE; DIADENOSINE TETRAPHOSPHATE; DIADENOSINE TRIPHOSPHATE; SURAMIN; UNCLASSIFIED DRUG;

ADRENAL GLAND; ATHEROSCLEROSIS; AUTONOMIC NERVE; BLOOD PRESSURE REGULATION; CALCIUM CELL LEVEL; CARDIOVASCULAR FUNCTION; CONFERENCE PAPER; DRUG ISOLATION; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; THROMBOCYTE; THROMBOCYTE AGGREGATION; VASOCONSTRICTION; VASODILATATION;

EID: 0030432512     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.1996.tb00053.x     Document Type: Conference Paper

References (51)

1. AGHA, A., SCHLÜTER, H., KÖNIG, V. BIEL, K., TEPEL, M. & ZIDEK, W. (1992). A novel platelet-derived renal vasoconstrictor agent in normotensives and essential hypertensives. J. Vasc. Res., 29, 281-289.
2. BAILEY, S.J. & HOURANI, S.M. (1995). Effects of suramin on contractions of the guinea-pig vas deferens induced by analogues of adenosine 5′-triphosphate. Br. J. Pharmacol., 114, 1125-1132.
3. BO, X., FISCHER, B., MAILLARD, M., JACOBSON, KA. & BURNSTOCK, G. (1994). Comparative studies on the affinities of ATP derivatives for P2X-purinoceptors in rat urinary bladder. Br. J. Pharmacol., 112, 1151-1159.
4. BUSSE, R., OGILVIE, A. & POHL, U. (1988). Vasomotor activity of diadenosine triphosphate and diadenosine tetraphosphate in isolated arteries. Am. J. Physiol., 254, H828-H832
5. CASTILLO, C.J., MORO, M.A., DEL VALLE, M., SILLERO, A., GARCIA, A.G. & SILLERO, M.A. (1992). Diadenosine tetraphosphate is coreleased with ATP and catecholamines from bovine adrenal medulla. J. Neurochem., 59, 723-732.
6. CASTRO, E., TORRES, M., MIRAS PORTUGAL, M.T. & GONZALEZ, M.P. (1990). Effect of diadenosine poly-phosphates on catecholamine secretion from isolated chromaffin cells. Br. J. Pharmacol., 100, 360-364.
7. FRUNGE, D., YOU, J., WAHLESTEDT C., & EDVINSSON, U. (1995). Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells. Eur. J. Pharmacol., 289, 135-149.
8. HODGAARD, H. & KLENOW, H. (1982). Abundant amounts of diadenosine 5′,5‴-P1,P4-tetraphosphate are present and releasable, but metabolically inactive, in human platelets. Biochem. J., 208, 737-742.
9. GOLDMAN, S.J. GORDON, E.L. & SLAKEY, L.L. (1986). Hydrolysis of diadenosine 5′,5″-P′,P″-triphosphate (Ap3A) by porcine aortic endothelial cells. Circ. Res., 59, 362-366.
10. HALL, D.A. & HOURANI, S.M. (1993). Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by- P2T-purinoceptors on human blood platelets. Br. J. Pharmacol., 108, 728-733.
11. HANKIN, S., MATTHEW, N., THORNE, H. & MCLENNAN, A.G. (1995). Diadenosine 5′,5‴ ′-P1,P4-tetraphosphate hydrolase is present in human erythrocytes, leukocytes and platelets. Int. J. Biochem. Cell Biol., 27, 201-206.
12. HARRISON, M.J. & BROSSMER, R. (1975). Inhibition of platelet aggregation and the platelet release reaction by alpha,omega diadenosine phosphates. FEBS Lett., 54, 57-60.
13. HEIDENREICH, S., TEPEL, M., SCHLUTER, H., HARRACH, B. & ZIDEK, W. (1995). Regulation of rat mesangial cell growth by diadenosine phosphates. J. Clin. Invest., 95, 2862-2867.
14. HILDERMAN, R.H., MARTIN, M., ZIMMERMAN, J.K. & PIVORUN, E.B. (1991). Identification of a unique membrane receptor for adenosine 5′,5‴-P1,P4-tetraphosphate. J. Biol. Chem., 266, 6915-6918.
15. HILDERMAN, R.H., LILIEN, J.E., ZIMMERMAN, J.E., TATE, D.H., DIMMICK, M.A. & JONES, G.B. (1994). Adenylated dinucleotide binding to the adenosine 5′,5‴-P1,P4-tetraphosphate mouse heart receptor. Biochem. Biophys. Res. Commun., 200, 749-755.
16. HOYLE, C.H., CHAPPLE, C.& BURNSTOCK, G. (1989). Isolated human bladder: evidence for an adenine dinucleotide acting on P2X-purinoceptors and for purinergic transmission. Eur. J. Pharmacol., 174, 115-118.
17. HOYLE, C., POSTORINO, A. & BURNSTOCK, G. (1995). Pre- and postjunctional effects of diadenosine polyphosphates in the guinea pig vas deferens. J. Pharm. Pharmacol., 47, 926-931.
18. IWATA, K., HARUKI, S. & KIMURA, T. (1995). High-performance liquid chromatographic determination of diadenosine 5′,5‴-p1,p4-tetraphosphate with precolumn fluorescence derivatization and its application to metabolism study in whole blood. J. Chromatogr., B: Biomed. Appl., 667, 339-343.
19. KIKUTA, Y., SEKINE, A., TEZUKA, S., OKADA, K., YAMAURA, T. & NAKAJIMA, H. (1994). Intravenous diadenosine tetraphosphate in dogs. Cardiovascular effects and influence on blood gases. Acta Anaesthesiol. Scand., 38, 284-288.
20. KLETA, R., HIRSCH, J., HEIDENREICH, S., SCHLUTER, H., ZIDER, W. & SCHLATTER, E. (1995). Effects of diadenosine polyphosphates, ATP and angiotensin II on membrane voltage and membrane conductances of rat mesangial cells. Pflugers Arch., 430, 713-720.
21. LOUIE, S., KIM, B.K. & ZAMECNIK, P. (1988). Diadenosine 5′,5‴-P1,P4-tetraphosphate, a potential antithrombotic agent. Thromb. Res., 49, 557-565.
22. LUTHJE, J. & OGILVIE, A. (1983). The presence of diadenosine 5′,5‴-P1,P3-triphosphate (Ap3A) in human platelets. Biochem. Biophys. Res. Commun., 115, 253-260.
23. LÜTHJE, J. & OGILVIE, A. (1984). Diadenosine triphosphate (Ap3A) mediates human platelet aggregation by liberation of ADP. Biochem. Biophys. Res. Commun., 118, 704-709.
24. LÜTHJE, J. & OGILVIE, A. (1985). Catabolism of Ap3A and Ap4A in human plasma. Purification and characterization of a glycoprotein complex with 5′-nucleotide phosphodiesterase activity. Eur. J. Biochem., 149, 119-127.
25. LÚTHJE, J. & OGILVIE, A. (1987). Catabolism of Ap4A and Ap3A in human serum. Identification of isoenzymes and their partial characterization. Eur. J. Biochem., 169, 385-388.
26. LÜTHJE, J. & OGILVIE, A. (1988). Catabolism of Ap4A and Ap3A in whole blood. The dinucleotides are long-lived signal molecules in the blood ending up as intracellular ATP in the erythrocytcs. Eur. J. Biochem., 173, 241-245.
27. LÜTHJE, J., BARINGER, J. & OGILVIE, A. (1985a). Highly efficient induction of human platelet aggregation in heparinized platelet-rich plasma by diadenosine triphosphate (Ap3A). Thromb. Haemost., 54, 469-471.
28. LÜTHJE, J., BARINGER, J. & OGILVIE, A. (1985b). Effects of diadenosine triphosphate (Ap3A) and diadenosine tetraphosphate (Ap4A) on platelet aggregation in unfractionated human blood. Blut, 51, 405-413.
29. MACKENZIE, I., KIRKPATRICK, K.A. & BURNSTOCK, G. (1988). Comparative study of the actions of AP5A and α,β-methylene ATP on nonadrenergic, noncholinergic neurogenic excitation in the guinea-pig vas deferens. Br. J. Pharmacol., 94, 699-706.
30. NEES, S. (1989). Coronary flow increases induced by adenosine and adenine nucleotides are mediated by the coronary endothelium: a new principle of the regulation of coronary flow. Eur. Heart J., 10(Suppl F), 28-15.
31. NORDONE, A.J. & PIVORUN, F.B. (1995). Cytosolic calcium responses to extracellular adenosine 5′,5‴-P1,P4-tetraphosphate in PC12 cells. Pharmacol. Biochem. Behav., 52, 85-91.
32. OGILVIE, A., LÜTHJE, J., POHL, U. & BUSSE, R. (1989). Identification and partial characterization of an adenosine(5′)tetraphospho(5′)adenosine hydrolase on intact bovine aortic endothelial cells. Biochem. J., 259, 97-103.
33. PINTOR, J., TORRES, M. & MIRAS-PORTUGAL, M.T. (1991). Carbachol induced release of diadenosine polyphosphates -Ap4A and Ap5A- from perfused bovine adrenal medulla and isolated chromaffin cells. Life Sci., 48, 2117-2124.
34. 2+ dependent release evoked by 4-aminopyridine and veratridine. Neurosci. Lett., 136, 141-144.
35. PINTOR, J., ROTLLAN, P., TORRES, M. & MIRAS-PORTUGAL, M.T. (1992b). Characterization and quantification of diadenosine hexaphosphate in chromaffin cells: granular storage and secretagogue-induced release. Anal. BiocHem., 200, 296-100.
36. PINTOR, J., PORRAS, A., MORA, F. & MIRAS-PORTUGAL, M.T. (1993). Amphetamine-induced release of diadenosine polyphosphates -Ap4A and Ap5A- from caudate putamen of conscious rat. Neurosci. Lett., 150, 13-16.
37. PINTOR, J., PORRAS, A., MORA, F. & MIRAS-PORTUGAL, MT. (1995). Dopamine receptor blockade inhibits the amphetamine-induced release of diadenosine polyphosphates, diadenosine tetraphosphate and diadenosine pentaphosphate, from neostriatum of the conscious rat. J. Neurochem., 64, 670-676.
38. POHL, U., OGILVIE, A., LAMONTAGNE, D. & BUSSE, R. (1991). Potent effects of AP3A and AP4A on coronary resistance and autacoid release of intact rabbit hearts. Am. J. Physiol., 260, H1692-H1697.
39. RALEVIC, V., HOYLE, C.H. & BURNSTOCK, G. (1995). Pivotal role of phosphate chain length in vasoconstrictor versus vasodilator actions of adenine dinucleotides in rat mesenteric arteries. J. Physiol. Lond., 483, 703-713.
40. RODRIGUEZ DEL CASTILLO, A., TORRES, M., DELICADO, E.G. & MIRAS-PORTUGAL, M.T. (1988). Subcellular distribution studies of diadenosine polyphosphates -Ap4A and Ap.5A- in bovine adrenal medulla: presence in chromaffin granules. J. Neurochem., 51, 1696-1703.
41. RODRIGUEZ PASCUAL, F., TORRES, M., ROTLLAN, P. & MIRAS-PORTUGAL, M.T. (1992). Extracellular hydrolysis of diadenosine polyphosphates, ApnA, by bovine chromaffin cells in culture. Arch. Biochem. Biophys., 297, 176-183.
42. 2+ activity and contraction of rat mesangial cells. Pflugers Arch., 430, 721-728.
43. SCHLÜTER, H., OFFERS, E., BRUGGEMANN, G., VAN DER GIFT, M., TEPEL, M., NORDHOFF, E., KARAS, M., SPIEKER, C., WITZEL, H. & ZIDEK, W. (1994). Diadenosine phosphates and the physiological control of blood pressure. Nature, 367, 186-188.
44. SCHULZE LOHOFF, E., ZANNER, S., OGILVIE, A. & STERZEL, R.B. (1995). Vasoactive diadenosine polyphosphates promote growth of cultured renal mesangial cells. Hypertension, 26, 899-904.
45. STONE, T.W. (1981). Actions of adenine dinucleotides on the vas deferens, guinea-pig taenia cacci and bladder. Eur. J. Pharmacol., 75, 93-102.
46. STONE, T.W. & PATON, D.M. (1989). Possible subtypes of ATP receptor producing contraction of rat vas deferens, revealed by cross-desensitisation. Gen. Pharmacol., 20, 61-64.
47. TEPEL, M. BACHMANN, J., SCHLUTER, H. & ZIDEK, W. (1996). Diadenosine polyphosphates increase cytosolic calcium and attenuate angiotensin-II-induced changes of calcium in vascular smooth muscle cells. J. Vasc Res., 33, 132-138.
48. WALKER, J. & HILDERMAN, R.H. (1993). Identification of a serine protease which activates the mouse heart adenosine 5′,5‴,P1,P4-tetraphosphate receptor. Biochemistry, 32, 3119-3123.
49. WALKER, J., LEWIS, T.E., PIVORUN, E.P. & HILDERMAN, R.H. (1993a). Activation of the mouse heart adenosine 5′,5‴-P1-P4-tetraphosphate receptor. Biochemistry, 32, 1264-1269.
50. WALKER, J.. BOSSMAN, P., LACKEY, B.R., ZIMMERMAN, J.K., DIMMICK, M.A. & HILDERMAN, R.H. (1993b). The adenosine 5′,5‴,P1,P4-tetraphosphate receptor is at the cell surface of heart cells. Biochemistry, 32, 14009-14014.
51. ZIMMERMANN, H., VOLKNANDT, W., WITTICH, B. & HAUSINGER, A. (1993). Synaptic vesicle life cycle and synaptic turnover. J. Physiol., Paris, 87, 159-170.